Dr. Thorsten Siess, Abiomed’s CTO and Inventor of Impella® Shares his Insights on the Impella® Platform of Devices
Dr. Thorsten Siess, Abiomed’s Chief Technology Officer and inventor of Impella® discusses how the world’s smallest heart pump transformed from a product to a platform. Listen in to learn how the Abiomed team is developing new features to satisfy the clinician community’s needs. What new features are being developed by Dr. Siess now? Press play … Continue reading “Dr. Thorsten Siess, Abiomed’s CTO and Inventor of Impella® Shares his Insights on the Impella® Platform of Devices”
Dr. Jason Wollmuth: Case Review of Complete Revascularization for a Patient in Cardiogenic Shock with Severe Multi-Vessel Disease
Dr. Jason Wollmuth presents a complex case of a patient in cardiogenic shock with severe multi-vessel disease. He feels that placing the Impella® heart pump made the procedure safer, and led to a more complete revascularization. Dr. Wollmuth also used a heart team decision-making approach. The patient is now walking up to a mile a … Continue reading “Dr. Jason Wollmuth: Case Review of Complete Revascularization for a Patient in Cardiogenic Shock with Severe Multi-Vessel Disease”
UCSD’s Dr. Mitul Patel shares a case of a shock patient transferred to his facility with an Impella CP® inserted for stabilization. Early hemodynamic support allowed Dr. Patel the time needed to assess this patient’s needs. The patient not only recovered fully but also displayed excellent systolic function recovery on a two month follow up. … Continue reading “How Impella® Provided Shock Patient Stabilization Prior to Transferring to Another Hospital”
The Protected PCI Blogging Team wants to take a moment to recognize the physicians who recently completed the “Impella Heart Team Certification Program.” This program is completed by those customers who are part of the Limited Market Release of the Impella RP Device. The Impella Heart Team Certification Program consists of two parallel sessions: one … Continue reading “Congratulations to March 2017 Impella Heart Team Certification Program Graduates”
This is a sample high-risk PCI algorithm used by Henry Ford Health System. Specifically, it is a Left Ventricular Mechanical Circulatory Support Device (MCS) Decision Tree Before Elective CTO and Complex PCI. IM2-277-16 v3
Dr. Jason Wollmuth of Portland Providence Medical Center shares his first Impella® case of a high-risk, surgically inoperable patient. Dr. Wollmuth describes Impella support as a game-changer as it allowed him to take his time to perform multiple passes down the left main, longer kissing balloon inflations and better bifurcation results. Tweet this, find educational opportunities near … Continue reading “Patient Benefits from High-Risk, Multi-Vessel Protected PCI with Impella CP”
Dr. Raja Hatem of Columbia University Medical Center discusses the importance of recognizing vital signs early in a cardiogenic shock case with multi-vessel intervention.
As part of our coverage and participation at this year’s TCT Conference, our employees are actively demonstrating the Impella catheter and how it can help elective and urgent high risk PCI patients that are hemodynamically stable presenting with severe coronary artery disease and depressed ejection fraction. Watch each short video below for more information.